Publications of T. Kümpfel
All genres
Journal Article (17)
2012
Journal Article
49 (9), pp. 558 - 562 (2012)
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. Journal of Medical Genetics 2011
Journal Article
258 (9), pp. 1665 - 1669 (2011)
De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. Journal of Neurology
Journal Article
77 (6), pp. 580 - 588 (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2007
Journal Article
13 (9), pp. 1138 - 1145 (2007)
Time of interferon- β 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients. Multiple Sclerosis
Journal Article
66 (2), pp. 295 - 303 (2007)
Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis. Clinical Endocrinology 2006
Journal Article
6 (19), doi:10.1186/1471-2377-6-19 (2006)
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurology
Journal Article
12 (7), pp. 432 - 437 (2006)
Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. Parkinsonism & Related Disorders 2005
Journal Article
62 (2), pp. 277 - 280 (2005)
Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Archives of Neurology 2001
Journal Article
86, pp. 1610 - 1615 (2001)
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized double blind trial. Journal of Clinical Endocrinology & Metabolism 2000
Journal Article
47, pp. 276 - 277 (2000)
Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Annals of Neurology
Journal Article
102, pp. 337 - 339 (2000)
Non-convulsive status epilepticus with marked neuropsychiatric manifestations and MRI changes after treatment of hypercalcaemia. Acta Neurologica Scandinavica
Journal Article
55, pp. 1231 - 1233 (2000)
Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS. Neurology
Journal Article
157 (2000)
Paroxetine for depersonalization associated with multiple sclerosis. American Journal of Psychiatry 1999
Journal Article
70, pp. 431 - 438 (1999)
Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology
Journal Article
53, pp. 772 - 777 (1999)
Dysregulation of the hypothalamic-pituitary-adrenal axis is related to the clinical course of multiple sclerosis. Neurology 1998
Journal Article
69, pp. 1111 - 1114 (1998)
Exazerbation von Tics durch Prednisolon. Nervenarzt
Journal Article
66, pp. 326 - 330 (1998)
Prolongierter nichtkonvulsiver Status epilepticus als klinische Erstmanifestation einer Epilepsie im Rahmen einer HIV-Infektion.: Fallbericht mit EEG- und MRT-Verlauf. Fortschritte der Neurologie/Psychiatrie Thesis - PhD (1)
1997
Thesis - PhD
Einfluß der Neuropeptide Substanz P und Calcitonin Gene-Related Peptide auf die zerebrale Mikrozirkulation in der Frühphase der experimentellen Pneumokokkenmeningitis. Dissertation, Ludwig-Maximilians-Universität, München (1997)